A recent NIH Trial has shown success in minimizing the effects of intracerebral hemorrhage through insertion of a minimally invasive catheter into the clot through a craniotomy. The catheter then injects 1 ml of clot-busting drugs followed by an 8 hour period of draining the lysed blood. The conservative procedure is repeated for 3-5 days as only very small dosages can be administered due to CT’s inability to directly monitor the drug’s safe distribution. We demonstrate how pressurized infusions can create broader treatments that lyse the clot rapidly while MRI visualizes the drug distributions to maintain safety.
This abstract and the presentation materials are available to members only; a login is required.